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AbstrACt
Objectives To measure the rates of lower respiratory 
tract infection (LRTI) and mortality following feeding 
gastrostomy (FG) placement in patients with learning 
disability (LD). Following this to compare these rates 
between those having LRTI prior to FG placement and 
those with no recent LRTI.
Design Retrospective cohort study.
setting and participants The study population included 
patients with LD undergoing FG placement in the ‘The 
Health Improvement Network’ database. Patients with 
LRTI in the year prior (LYP) to their FG placement were 
compared with patients without a history of LRTI in the 
year prior (non-LYP) to FG placement. FG placement and 
LD were identified using Read codes previously developed 
by an expert panel.
Main outcome measures Incidence rate ratio (IRR) of 
developing LRTI and mortality following FG, comparing 
patients with LRTI in the year prior to FG placement to 
patients without a history of LRTI.
results 214 patients with LD had a FG inserted including 
743.4 person years follow-up. 53.7% were males and 
the median age was 27.6 (IQR 19.6 to 38.6) years. 27.1% 
were in the LYP patients. 18.7% had a LRTI in the year 
following FG, with an estimated incidence rate of 254 per 
1000-person years. Over the study period the incidence 
rate of LRTI in LYP patients was 369 per 1000-person 
years, in non-LYP patients this was 91 per 1000-person 
years (adjusted IRR 4.21 (95% CI 2.68 to 6.63) p<0.001). 
27.1% of patients died during study follow-up. Incidence 
rate of death was 80 and 45 per 1000-person year for 
LYP and non-LYP patients, respectively (adjusted IRR 1.80 
(1.00 to 3.23) p=0.05).
Conclusion In LD patients, no clinically meaningful 
reduction in LRTI incidence was observed following FG 
placement. Mortality and LRTI were higher in patients 
with at least one LRTI in the year preceding FG placement, 
compared with those without a preceding LRTI.
IntrODuCtIOn
Patients with learning disability (LD) are 
known to have high incidence of aspiration 
on video fluoroscopy.1 For this reason the 
National Patient Safety Agency review in 2004 
considered swallowing difficulties to be a 
key cause for concern in this group.2 Aspira-
tion is associated with recurrent episodes of 
pneumonia, often including hospitalisation. 
This contributes to the high incidence of 
chronic lung disease3 and disproportionately 
high mortality from respiratory conditions 
in this patient cohort.4 Patients with LD may 
undergo feeding gastrostomy (FG) insertion 
in an effort to reduce aspiration, usually as 
part of a multifactorial indication including 
the need for nutritional support.
Patients who receive nutrition through a 
FG are still at risk of aspiration. A Japanese 
study looking at elderly patients demon-
strated that in those with prior aspiration 
pneumonia mortality following FG insertion 
was high and the the most common cause of 
mortality was pneumonia.5 FG placement also 
strengths and limitations of the study
 ► This study utilised The Health Improvement Network 
(THIN). THIN is a primary care database including 
6% of the UK population, which is representative of 
national demographics, therefore providing a large 
cohort for analysis.
 ► Patients with learning disability were identified using 
Read codes developed by an expert panel for use in 
research, providing a robust mechanism to identify 
such patients.
 ► Feeding gastrostomy (FG) is incompletely coded in 
THIN, therefore new tube feed prescription is used 
as a surrogate of FG placement, however some cas-
es will not be identified.
 ► Respiratory tract infection and death are largely 
accurately coded therefore the described rates of 
these outcomes are robust.
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did not improve quality of life in a longitudinal study of 
40 patients with LD.6
There is no current evidence describing the outcomes 
from FG insertion in patients with LD with respect to 
respiratory tract infections. Patients with LD are often 
excluded from clinical studies, despite the recognition 
that this group has greater healthcare needs, and poorer 
engagement with healthcare services. For this reason they 
have been described as a ‘Cinderella population’.7
Admission to hospital for patients with LD is often 
challenging for both the patients and staff. Best interest 
decisions and delegated consent for FG placement are 
often required. Often the procedure is traumatic for the 
patient and carers. It is therefore important to ensure 
that FG placement is in the LD patient’s best inter-
ests. Equally important is that the information given to 
family members and carers, who participate in the deci-
sion-making process, is evidence based.
The aim of this study was to examine the impact of 
FG placement on the risk of respiratory tract infections 
and mortality within the LD cohort using The Health 
Improvement Network (THIN) primary care database.
MethODs
The present study is a retrospective, population-based 
cohort study of all patients with LD, whom underwent FG 
placement. Patients were segregated by those with coded 
lower respiratory tract infection (LRTI) including specific 
aspiration pneumonia codes within 1 year prior (LYP) to 
FG placement and those without (non-LYP). LYP patients 
were considered to be those at high risk for aspiration.
Data source
THIN represents a group of general practices (primary 
care) covering 6% of the UK population, which is repre-
sentative of the UK population structure.8 Individual 
practices were eligible for inclusion in the study from the 
later of the following two dates to ensure that the prac-
tice was making full use of the electronic medical record 
(EMR): 1 year after the date their EMR was installed; and 
after the practice’s acceptable mortality recording date. 
To ensure there was sufficient time to record baseline 
comorbidities data, individual patients were eligible for 
inclusion from the date their practice became eligible 
for inclusion in the study or 1 year after registration with 
their practice if this date was later. Available information 
includes demographical, procedural and mortality data. 
Diagnosis and clinical presentations are recorded in the 
Read code hierarchical coding system.9
THIN data access was provided by IQVIA to the Univer-
sity of Birmingham under the NHS South-East multi-
centre research ethics committee approval in 2003, prior 
to independent scientific review. This study was granted 
study specific approval (SRC18THIN008) from the IMS 
Health Scientific review committee.
study population
Patients with LD were identified by Read codes devel-
oped by NHS Digital for a previous study (online 
supplementary data 1). A panel of four experts reviewed 
each potential Read code. A code was included If there 
was agreement by three or more experts.10
FG placement was identified by one of two methods; 
Read code for FG placement, or first prescription of 
non-oral, enteric, tube feed from the British National 
Formulary. Although these may also be used with a 
nasogastric tube, it is highly unlikely that this would be 
performed outside of a hospital setting.
Patients aged 16 to 46 with an LD code from any time 
point and incident FG placement between May 1995 and 
May 2017 were included.
Co-variates and outcome measures
Further variables sought included age, gender, smoking 
status, body mass index (BMI), Townsend deprivation 
index, epilepsy and Charlson comorbidity score.
Episodes of LRTI were identified by Read code following 
the FG placement. Mortality was also sought in the THIN 
database. The full list of Read codes for covariates can be 
found in online supplementary data 1.
statistical analysis
Demographic characteristics were described for the LYP, 
non-LYP and total cohorts. Age is converted to quintiles 
because any relationship was considered unlikely to be 
linear. Baseline variables were compared between LYP 
and non-LYP cohorts.
The incidence rate (IR) of LRTI and mortality within 
1 year of FG placement are reported for LYP and non-LYP 
cohorts. The rate of LRTI in the year prior to FG place-
ment was also reported.
IRs were calculated for LRTI and mortality at any time 
point following FG placement, in the LYP and non-LYP 
cohorts. Incidence rate ratios (IRR) and 95% CIs are 
reported. Median time to event and IQR are reported 
for LRTI and mortality. Cumulative incidence charts 
were plotted for mortality and LRTI by LYP group and 
compared with competing risk regression to allow for 
competing risks and time to event data.
A multivariable Poisson regression model was 
constructed for factors associated with LRTI up to 1 year 
after FG placement. Covariates included age, gender, 
deprivation, Charlson score category (0 or 1+) epilepsy 
and LYP history.
All statistical analysis was undertaken in Stata V.15.11 
The threshold for statistical significance was set at p<0.05.
Patient and public involvement
Neither patients nor the public were involved in the 
development of the research question or design of the 
study. Patients or the public were not involved in the data 
collection or analysis stages of the paper. As the study 
utilises anonymised data, it is not possible to disseminate 
the study findings to the specific patients included. The 
study is published open access and therefore clinicians 
who look after patients relevant to this study will be able 
to view the findings to inform their practice.
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results
Patient demographics
There were 38 521 patients with an LD code in THIN, 
of whom 214 patients met the inclusion criteria for FG 
placement between age 16 to 46. The median age of the 
total cohort was 27.6 (IQR 19.6 to 38.6) years and 53.7% 
were male. Charlson comorbidity scores were 0, 1, 2 and 
3 or more in 155 (72.4%), 39 (18.2%), 9 (4.2%) and 11 
(5.1%), respectively and 69.6% had a coded diagnosis of 
epilepsy. BMI was available in only 82 (38.3%) patients, 
median 20 kg/m2 (IQR 16.5 to 24.2 kg/m2).
There were 58 LYP patients, 55.2% of whom were male, 
median age 30.8 (IQR 19.4 to 39.1) years, and there were 
97.6 person-years follow-up. One hundred and fifty-six 
non-LYP patients were included, 53.2% of whom were 
male, median age 27.0 (IQR 19.9 to 36.7) years. The 
non-LYP patients had 645.8 person-years follow-up. Full 
cohort demographics for the whole study population and 
split by exposure are shown in table 1.
lower respiratory tract infection in the year after feeding 
gastrostomy placement
Forty patients developed LRTI within 1 year of FG place-
ment, which was more common in the LYP patients 
compared with the non-LYP group; IR 606 per 1000-
person years and 149 per 1000-person years, respectively. 
Unadjusted IRR 4.07 (95% CI 2.09 to 8.06), (p<0.001) 
and adjusted IRR 4.05 (2.08 to 7.87), (p<0.001).
lower respiratory tract infections in the whole follow-up 
period
Over the study period IR for LRTI in the LYP group was 
369 per 1000-person years. In the non-LYP group this was 
91 per 1000-person years, unadjusted IRR 4.04 (95% CI 
2.59 to 6.21, p<0.001). (table 2 and figure 1). The time 
from FG placement to LRTI in the whole study popula-
tion was 1.33 (IQR 0.4 to 3.72) years. In LYP patients this 
was 0.64 (0.27 to 1.84) years and in the non-LYP patients 
2.37 (0.71 to 4.90) years.
In a multivariable Poisson regression model male 
gender (IRR 2.10 (95% CI 1.03 to 4.29), p=0.042), age 
33 to 40 years (3.36 (1.11 to 10.16), p=0.031), age >40 
years (5.22 (1.73 to 15.75), p=0.003) and LYP (4.05 
(2.09 to 7.87), p<0.001) were significantly associated with 
developing LRTI in the year following FG placement 
(table 3).
lower respiratory tract infection before and after feeding 
gastrostomy
The proportion with LYP was 27.1% and 18.7% devel-
oped LRTI in the year following FG placement, although 
with less than 1 year of follow-up in some patients. The 
LRTI incidence ratio for the complete cohort in the year 
prior to FG placement was 317 per 1000-person years 
compared with 254 per 1000-person years in the year after 
FG placement.
Mortality
Over the study period 58 patients died and median age at 
death was 38.2 (27.8 to 42.0) years. The IR in LYP patients 
was 80 per 1000-person years and 45 per 1000 person 
years in the non-LYP patients (unadjusted IRR 1.76 (95% 
CI 1.00 to 3.11), p=0.047) (table 2 and figure 2).
In a multivariable Poisson regression model, age 
33 to 40 years (2.59 (1.03 to 6.52), p=0.043) and age >40 
years (2.62 (1.01 to 6.77), p=0.047) were significantly 
Table 1 Patient demographics
Non-LYP (n=156) LYP* (n=58) Total (n=214) P value
Gender Male 83 (53.2) 32 (55.2) 115 (53.7) p= 0.8
Female 73 (46.8) 26 (44.8) 99 (46.3)
Median age in years 
(IQR)
27.0
(19.9-36.7)
30.8
(19.4-39.1)
27.6
(19.6-8.6)
p=0.6
Townsend 1 31 (19.9) 9 (15.5) 40 (18.7) p=0.3
2 30 (19.2) 16 (27.6) 46 (21.5)
3 38 (24.4) 14 (24.1) 52 (24.3)
4 21 (13.5) 12 (20.7) 33 (15.4)
5 25 (16.0) 4 (6.9) 29 (13.6)
Missing 11 (7.1) 3 (5.2) 14 (6.5)
Epilepsy Yes 103 (66.0) 46 (79.3) 149 (69.6) p=0.06
No 53 (34.0) 12 (20.7) 65 (30.4)
Charlson 
comorbidity score
0 115 (73.7) 40 (69.0) 155 (72.4) p=0.53
1 27 (17.3) 12 (20.7) 39 (18.2)
2 5 (3.2) 4 (6.9) 9 (4.2)
3+ 9 (5.8) 2 (3.5) 11 (5.1)
Values are n(%) unless otherwise specified.
LYP, LRTI in the year prior to feeding gastrostomy placement.
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associated with mortality during study follow-up following 
FG placement in comparison to age group <19 years. LYP 
(1.80 (1.00 to 3.23), p=0.05) was of borderline signifi-
cance in this adjusted model (table 4).
DIsCussIOn
This is the first study to assess the outcomes of FG inser-
tion in a cohort of patients with LD. No reduction in 
LRTI following FG placement was observed. Further-
more, patients having one or more LRTIs prior to their 
FG (LYP) were more likely to have LRTIs after FG place-
ment, both in the first year after their FG and in long-
term follow-up. Patients with one or more LRTIs prior 
to FG placement also had increase in mortality over the 
study period. Male gender was associated with increased 
LRTI within 1 year. Increasing age was associated with 
both increased mortality and LRTI within 1 year of FG 
placement.
There are no other studies looking at outcomes 
following FG placement specific to patients with LD. A 
prospective FG audit including 350 FG placements over 
571 person years of data found a 1 year mortality of 35%, 
significantly higher than reported in the above study.12 
However, the median age was 62 years compared with 
28 years in the present study and all indications were 
included. Thirty-one of 350 FG were placed in patients 
with LD in whom five (16.1%) died over median 20 
months follow-up. In the present study 11 (5.1%) died 
within 12 months and over the study period 55 (25.7%) 
patients died, although with a median time to death of 3.5 
years. Although the proportions observed are different, 
only small numbers of deaths are observed and therefore 
comparison may be misleading. There is also likely to be 
variation in practice between providers, with a national 
overview provided by the present study compared with a 
single provider in the study by Clarke, Pitts, Latchford & 
Lewis.12
Short-term mortality could not be addressed in this 
study as there were too few outcomes despite the sample 
size. There was also a wide variation in time to LRTI with 
large IQRs. Therefore, although there appears to be 
shorter time to LRTI following FG placement in patients 
in the LYP patient group compared with the non-LYP 
group, this result requires further evaluation before any 
implications for clinical practice can be considered.
LRTI are used as a surrogate of aspiration pneumonia 
in the present study. Although there are codes specifically 
for aspiration pneumonia, the study included all LRTI 
codes to provide good sensitivity. In patients who have a 
FG in situ or proceed to have a FG placed up to 1 year 
later, it was assumed that aspiration at least contributed 
to their LRTI.
A key strength of this analysis compared with others 
examining the impact of FG placement is the use of 
primary care data. The THIN database is an important 
tool to examine the LD population. The database is 
recognised to have a high accuracy and is therefore used 
Table 2 Incidence rate ratio of lower respiratory tract infections and mortality following FG placement
LRTI within 1 year LRTI at any time Mortality at any time
LYP Non-LYP LYP Non- LYP LYP Non- LYP
Events 22 18 36 59 20 38
Person years 36 121 98 645 251 842
Incidence rate
(per 1000)
606 149 369 91 80 45
Incidence rate ratio 4.07
(2.09–8.06)
4.04
(2.59–6.21)
1.76
(1.00–3.11)
P value <0.001 P=0.001 P=0.047
Incidence rate ratio 
(adjusted)
4.05
(2.08–7.87)
4.21
(2.68–6.63)
1.80
(1.00–3.23)
P value (adjusted) <0.001 <0.001 P=0.05
FG, feeding gastrostomy; LRTI, lower respiratory tract infection; LYP, LRTI in the year prior to feeding gastrostomy placement. 
Figure 1 Cumulative incidence regression for lower 
respiratory tract infections following FG placement. FG, 
feeding gastrostomy. 
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for analysis for a wide range of conditions and outcomes. 
Specific benefits of the present study include a relatively 
large number of patients with LD with robust diagnostic 
and demographical data. Respiratory infections in this 
cohort are often managed in primary care and as such, 
only a small minority of cases present to secondary care. 
Therefore, presentation to primary care is a more sensi-
tive measure of such infections.
Patients with LD are often challenging to identify from 
medical records. The Read codes used in the current 
cohort were developed by an expert group, in which 
codes were only included in the final set if three out of 
four panel members agreed that the code was repre-
senting a group of patients with LD. This set of Read codes 
has been utilised a number of studies previously.13 This 
provides reassurance that the cohort in the present study 
accurately represents patients with LD. Although over 200 
were included, and most clinically significant associations 
are likely to have been identified, a larger cohort would 
have allowed detection of more subtle factors, including 
an accurate estimate of their effects.
Identification of patients undergoing FG placement 
in the THIN database was also difficult. As a procedure 
performed in secondary care, the FG placement was not 
always coded in primary care data. Therefore, first feed 
prescription was used as a surrogate marker to identify 
when a FG had been placed. Despite these methods, it is 
likely that not all FG placements are captured within the 
data; however, we can be confident that those included 
represent a cohort of patients with LD undergoing FG 
placement. Unfortunately Read codes describing treat-
ment decisions around FG placement also prevented 
identification of a cohort in whom FG placement was 
recommended but rejected. Therefore, comparison of a 
cohort with FG in situ to a control group without FG was 
not feasible.
The indication for FG placement, for example, 
dysphagia, recurrent aspiration or insufficient calorific 
intake, could not be identified in this study, which is a 
significant limitation. It is accepted that FG placement 
will be for inadequate oral nutrition which may have 
multifactorial causes. By seeking respiratory tract infec-
tions within 1 year prior to FG placement, patients in 
whom this is a component of the indication for FG place-
ment are identified and compared with those with other 
indications.
Table 3 Poisson regression model for lower respiratory tract infection within 1 year of FG placement
Incidence
rate ratio 95% CI P value
Age quintile <19 1 – –
19 to 24 1.38 0.43 to 4.43 0.586
24 to 33 1.28 0.36 to 4.63 0.699
33 to 40 3.36 1.11 to 10.16 0.031
>40 5.22 1.72 to 15.75 0.003
Gender (male) 2.10 1.03 to 4.29 0.042
Epilepsy 1.73 0.78 to 3.81 0.177
Charlson score 1 or above 1.73 0.86 to 3.47 0.125
Townsend deprivation 
score (5 is the most 
deprived)
1 1 - -
2 0.68 0.25 to 1.83 0.441
3 1.11 0.43 to 2.86 0.822
4 0.67 0.21 to 2.19 0.513
5 0.68 0.17 to 2.70 0.580
Missing 0.54 0.10 to 2.80 0.462
LRTI in the year prior to PEG placement (LYP) 4.05 2.08 to 7.87 <0.001
FG, feeding gastrostomy; LRTI, lower respiratory tract infection; LYP, LRTI in the year prior to feeding gastrostomy placement; PEG, 
percutaneous endoscopic gastrostomy. 
Figure 2 Cumulative incidence regression for mortality 
following FG placement. FG, feeding gastrostomy.
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Unfortunately, data on BMI was missing in a very high 
proportion of patients. As such this could not be included 
in the analysis. It is hypothesised that patients requiring a 
FG are less mobile and therefore, in the absence of appro-
priate equipment, they do not routinely have their weight 
checked and recorded in primary care.
COnClusIOn
This novel population-based study demonstrates that 
FG placement does not appear to confer a reduction in 
LRTIs in the LD cohort. A small increase in mortality was 
also noted in patients with a recent history of respiratory 
tract infections prior to FG placement. Physicians making 
decisions regarding FG placement in patients with LD 
should incorporate this into their assessment of risk and 
benefit and ensure patients, carers and family members 
are aware of likely outcomes following FG placement. 
Further research is required in patients with LD to estab-
lish sub-groups that are most likely to benefit from FG 
placement.
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Table 4 Poisson regression model for mortality following FG placement
Incidence
rate ratio 95% CI P value
Age quintile <19 1 – – 
19 to 24 1.84 0.71 to 4.82 0.210
24 to 33 1.65 0.62 to 4.39 0.315
33 to 40 2.59 1.03 to 6.52 0.043
>40 2.62 1.01 to 6.77 0.047
Gender (male) 0.93 0.54 to 1.61 0.792
Epilepsy 0.80 0.44 to 1.44 0.452
Charlson score 1 or above 1.21 0.68 to 2.18 0.508
Townsend deprivation 
score (5 is the most 
deprived)
1 1 – – 
2 0.57 0.25 to 1.30 0.183
3 0.63 0.29 to 1.38 0.250
4 0.79 0.33 to 1.88 0.594
5 0.42 0.15 to 1.17 0.098
Missing 0.32 0.7 to 1.49 0.146
LRTI in the year prior to PEG placement (LYP) 1.80 1.00 to 3.23 0.050
FG, feeding gastrostomy; LRTI, lower respiratory tract infection; LYP, LRTI in the year prior to feeding gastrostomy placement; PEG, 
percutaneous endoscopic gastrostomy. 
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